- Home
- MGRM vs APLT Comparison
MGRM vs APLT Comparison
Compare MGRM & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- APLT
- Stock Information
- Founded
- MGRM 2016
- APLT 2016
- Country
- MGRM United States
- APLT United States
- Employees
- MGRM N/A
- APLT N/A
- Industry
- MGRM Medical/Dental Instruments
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- MGRM Health Care
- APLT Health Care
- Exchange
- MGRM Nasdaq
- APLT Nasdaq
- Market Cap
- MGRM 232.0M
- APLT 63.6M
- IPO Year
- MGRM N/A
- APLT 2019
- Fundamental
- Price
- MGRM $5.74
- APLT $0.42
- Analyst Decision
- MGRM Strong Buy
- APLT Buy
- Analyst Count
- MGRM 1
- APLT 6
- Target Price
- MGRM $5.40
- APLT $6.10
- AVG Volume (30 Days)
- MGRM 96.6K
- APLT 876.2K
- Earning Date
- MGRM 11-13-2025
- APLT 11-06-2025
- Dividend Yield
- MGRM N/A
- APLT N/A
- EPS Growth
- MGRM N/A
- APLT N/A
- EPS
- MGRM N/A
- APLT N/A
- Revenue
- MGRM N/A
- APLT $121,000.00
- Revenue This Year
- MGRM N/A
- APLT N/A
- Revenue Next Year
- MGRM N/A
- APLT $5,931.24
- P/E Ratio
- MGRM N/A
- APLT N/A
- Revenue Growth
- MGRM N/A
- APLT N/A
- 52 Week Low
- MGRM $1.92
- APLT $0.30
- 52 Week High
- MGRM $6.02
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- MGRM 58.97
- APLT 40.70
- Support Level
- MGRM $5.67
- APLT $0.40
- Resistance Level
- MGRM $5.89
- APLT $0.46
- Average True Range (ATR)
- MGRM 0.14
- APLT 0.03
- MACD
- MGRM -0.04
- APLT -0.01
- Stochastic Oscillator
- MGRM 52.46
- APLT 17.89
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.